Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2009 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome.
Tran NL, McDonough WS, Savitch BA, Fortin SP, Winkles JA, Symons M, Nakada M, Cunliffe HE, Hostetter G, Hoelzinger DB, Rennert JL, Michaelson JS, Burkly LC, Lipinski CA, Loftus JC, Mariani L, Berens ME. Tran NL, et al. Among authors: savitch ba. Cancer Res. 2006 Oct 1;66(19):9535-42. doi: 10.1158/0008-5472.CAN-06-0418. Cancer Res. 2006. PMID: 17018610 Free article.
The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, Berens ME. Tran NL, et al. Among authors: savitch ba. J Biol Chem. 2005 Feb 4;280(5):3483-92. doi: 10.1074/jbc.M409906200. Epub 2004 Dec 16. J Biol Chem. 2005. PMID: 15611130 Free article.